Track topics on Twitter Track topics that are important to you
Palforzia, which was formerly known as AR101, has been indicated in the US for the mitigation of anaphylaxis and other allergic reactions following accidental exposure to peanut. The
The post Aimmune’s Palforzia gets FDA approval for treatment of peanut allergy appeared first on Pharmaceutical Business review.
Original Article: Aimmune’s Palforzia gets FDA approval for treatment of peanut allergyNEXT ARTICLE
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...